Dimebon ameliorates amyloid-β induced impairments of mitochondrial form and function

Journal of Alzheimer's Disease

Volumn 31, Issue 1, 2012, Pages 21-32

  Eckert, Schamim H ^a   Eckmann, Janett ^a   Renner, Kathrin ^b   Eckert, Gunter P ^a   Leuner, Kristina ^a,c   Muller, Walter E ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Alzheimer's disease; amyloid ; A PP mutation; Dimebon; latrepirdine; mitochondrial dynamics; mitochondrial dysfunction; mitochondrial mass; mitochondrial morphology; mitochondrial respiratory complexes; OXPHOS

Indexed keywords

AMYLOID BETA PROTEIN; DIMEBON;

ALZHEIMER DISEASE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFICACY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; RESPIRATORY CHAIN;

EID: 84863944817     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120310     Document Type: Article

References (67)

1. Muller WE, Eckert A, Kurz C, Eckert GP, Leuner K (2010) Mitochondrial dysfunction: Common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol Neu-robiol 41, 159-171.
2. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9, 505-518. (Pubitemid 351873464)
3. Griparic L, Head B, van der Bliek AM (2004) Mitochondrial fission and fusion machineries, In: Mitochondrial Function and Biogenetics, Koehler C, Bauer MF, Eds. Springer Inc., Heidelberg, p. 227.
4. Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T, Rossignol R (2007) Mitochondrial bioenergetics and structural network organization. J Cell Sci 120, 838-848. (Pubitemid 46523485)
5. Benard G, Rossignol R (2008) Ultrastructureof the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal 10, 1313-1342.
6. Romanello V, Guadagnin E, Gomes L, Roder I, Sandri C, Petersen Y, Milan G, Masiero E, Del Piccolo P, Foretz M, Scorrano L, Rudolf R, Sandri M (2010) Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J 29, 1774-1785.
7. Civitarese AE, Ravussin E (2008) Mitochondrial energetics and insulin resistance. Endocrinology 149, 950-954.
8. Leuner K, Schutt T, Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE, Palmiter RD, Brandt U, Drose S, Wittig I, Willem M, Haass C, Reichert AS, Mueller WE (2012) Mitochondria-derived ROS lead toenhanced amyloid beta formation. Antiox Redox Signal, doi: 10.1089/ars.2011.4173.
9. Eckert GP, Wood WG, Mueller WE (2001) Effects of aging and beta-amyloid onthe propertiesofbrain synaptic and mito-chondrial membranes. J Neural Transm 108, 1051-1064. (Pubitemid 32802102)
10. Leutner S, Eckert A, Mueller WE (2001) ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain. J Neural Transm 108, 955-967. (Pubitemid 32802093)
11. Clayton DA, Doda JN, Friedberg EC (1974) The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc Natl Acad Sci USA 71, 2777-2781.
12. Croteau DL, Stierum RH, Bohr VA (1999) Mitochondrial DNA repair pathways. Mutat Res 434, 137-148. (Pubitemid 29352252)
13. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. (Pubitemid 44622683)
14. Paradies G, Petrosillo G, Paradies V, Ruggiero FM (2010) Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging. Free Radic Biol Med 48, 1286-1295.
15. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60, 748-766.
16. Rhein V, Eckert A (2007) Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function-role of glucose metabolism and insulin signalling. Arch Physiol Biochem 113, 131-141. (Pubitemid 47547386)
17. Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887. (Pubitemid 40017692)
18. Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14, 45-53.
19. Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49, 618-632. (Pubitemid 41546661)
20. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-Beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 105, 19318-19323.
21. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29, 9090-9103.
22. Rui Y, Tiwari P, Xie Z, Zheng JQ (2006) Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hip-pocampal neurons. J Neurosci 26, 10480-10487. (Pubitemid 44564598)
23. Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP Jr, Miller SW, Davis RE, Parker WD (2000) Abnormal mitochondrial morphology insporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol 162, 37-50. (Pubitemid 30170099)
24. Reddy PH (2009) Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp Neurol 218, 286-292.
25. Su B, Wang X, Bonda D, Perry G, Smith M, Zhu X (2010) Abnormal mitochondrial dynamics-a novel therapeutic target for Alzheimer's disease? Mol Neurobiol 41, 87-96.
26. Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA (2010) Mitochondria: A therapeutic targetinneurodegeneration. Biochim Biophys Acta 1802, 212-220.
27. Sachdeva D, Burns A (2011) Dimebolin in dementia. CNS Neurosci Ther 17, 199-205.
28. Bachurin S, Bukatina E, Lermontova N, Tkachenko S, Afanasiev A, Grigoriev V, Grigorieva I, Ivanov Y, Sablin S, Zefirov N (2001) Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer. Ann N Y Acad Sci 939, 425-435. (Pubitemid 32620096)
29. Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D (2008) Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: A randomised, double-blind, placebo-controlled study. Lancet 372, 207-215. (Pubitemid 351978110)
30. Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, Seely L, Walker F, Feigin A (2010) A randomized, placebo-controlled trial of latrepirdine in Hunt-ington disease. Arch Neurol 67, 154-160.
31. Vignisse J, Steinbusch HW, Bolkunov A, Nunes J, Santos AI, Grandfils C, Bachurin S, Strekalova T (2011) Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks inmice. Prog Neuropsychophar- macol Biol Psychiatry 35, 510-522.
32. Wang J, Ferruzzi MG, Varghese M, Qian X, Cheng A, Xie M, Zhao W, Ho L, Pasinetti GM (2011) Preclinical study of dimebon on beta-amyloid-mediated neuropathology in Alzheimer's disease. Mol Neurodegener 6, 7.
33. Giorgetti M, Gibbons JA, Bernales S, Alfaro IE, Drieu LR, Cremers T, Altar CA, Wronski R, Hutter-Paier B, Protter AA (2010) Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism. J Pharmacol Exp Ther 333, 748-757.
34. Schaffhauser H, Mathiasen JR, Dicamillo A, Huffman MJ, Lu LD, McKenna BA, Qian J, Marino MJ (2009) Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities. Biochem Pharmacol 78, 1035-1042.
35. Webster SJ, Wilson CA, Lee CH, Mohler EG, Terry AV Jr, Buccafusco JJ (2011) The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. Br J Pharmacol 164, 970-978.
36. Medivation (2010) Pfizer And Medivation Announce Results From Two Phase 3 Studies in Dimebon (latrepir-dine*) Alzheimer's Disease Clinical Development Program, http://investors.medivation.com/releasedetail.cfm? releaseid= 448818, 03/10/10, Accessed February 10, 2012.
37. Jones RW (2010) Dimebon disappointment. Alzheimers Res Ther 2, 25.
38. Medivation, Pfizer And Medivation Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer's Disease. Dimebon Did Not Meet Primary Efficacy End-points, http://investors.medivation.com/releasedetail.cfm? ReleaseID=639515 Accessed March 13, 2012.
39. Eckert A, Steiner B, Marques C, Leutz S, Romig H, Haass C, Muller WE (2001) Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. J Neurosci Res 64, 183-192.
40. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, Muller-Spahn F, Haass C, Czech C, Pradier L, Muller WE, Eckert A (2004) Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279, 50310-50320. (Pubitemid 39577847)
41. Kuznetsov AV, Strobl D, Ruttmann E, Konigsrainer A, Mar-greiter R, Gnaiger E (2002) Evaluation of mitochondrial respiratory function in small biopsies of liver. Anal Biochem 305, 186-194. (Pubitemid 34666791)
42. Hutter E, Renner K, Pfister G, Stockl P, Jansen-Durr P, Gnaiger E (2004) Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem J 380, 919-928. (Pubitemid 38850535)
43. Stadlmann S, Renner K, Pollheimer J, Moser PL, Zeimet AG, Offner FA, Gnaiger E (2006) Preserved coupling of oxida-tive phosphorylation but decreased mitochondrial respiratory capacity in IL-1beta-treated human peritoneal mesothelial cells. Cell Biochem Biophys 44, 179-186. (Pubitemid 43172316)
44. Keil U, Scherping I, Hauptmann S, Eckert A, Muller WE (2005) Stabilization of mitochondrial function by piracetam. Pharmacopsychiatry 38, 253-253.
45. Leuner K, Kurz C, Guidetti G, Orgogozo JM, Muller WE (2010) Improved mitochondrial function in brain aging and Alzheimer disease-the new mechanism of action of the old metabolic enhancer piracetam. Front Neurosci 4, pii 44.
46. Hood DA (2001) Contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 90, 1137-1157. (Pubitemid 32171405)
47. Koopman WJ, Visch HJ, Verkaart S, van den Heuvel LW, Smeitink JA, Willems PH (2005) Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am J Physiol Cell Physiol 289, C881-C890. (Pubitemid 41361644)
48. Sokoloff L (1977) Relation between physiological function and energy metabolism in the central nervous system. J Neu-rochem 29, 13-26. (Pubitemid 8150483)
49. Parker WD Jr, Swerdlow RH (1998) Mitochondrial dysfunction in idiopathic Parkinson disease. Am J Hum Genet 62, 758-762. (Pubitemid 28194314)
50. Liang CL, Wang TT, Luby-Phelps K, German DC (2007) Mitochondria massis lowinmouse substantia nigra dopamine neurons: Implications for Parkinson's disease. Exp Neurol 203, 370-380. (Pubitemid 46149588)
51. Holloszy JO, Oscai LB, Don IJ, Mole PA (1970) Mito-chondrial citric acid cycle and related enzymes: Adaptive response to exercise. Biochem Biophys Res Commun 40, 1368-1373.
52. Williams RS, Salmons S, Newsholme EA, Kaufman RE, Mellor J (1986) Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. J Biol Chem 261, 376-380. (Pubitemid 16103956)
53. Lermontova NN, Redkozubov AE, Shevtsova EF, Serkova TP, Kireeva EG, Bachurin SO (2001) Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca (2+) channels. Bull Exp Biol Med 132, 1079-1083. (Pubitemid 34295938)
54. Grigorev VV, Dranyi OA, Bachurin SO (2003) Comparative study of action mechanisms of dimebon and memantine on AMPA-and NMDA-subtypes glutamate receptors in rat cerebral neurons. Bull Exp Biol Med 136, 474-477. (Pubitemid 39137308)
55. Wu J, Li Q, Bezprozvanny I (2008) Evaluation of Dimebon in cellular model of Huntington's disease. Mol Neurodegener 3, 15.
56. Naga KK, Geddes JW (2011) Dimebon inhibits calcium-induced swelling of rat brain mitochondria but does not alter calcium retention or cytochrome C release. Neuromolecular Med 13, 31-36.
57. Zhang S, Hedskog L, Petersen CA, Winblad B, Ankarcrona M (2010) Dimebon (latrepirdine) enhances mitochondrial function and protects neuronal cells from death. J Alzheimers Dis 21, 389-402.
58. Bachurin SO, Shelkovnikova TA, Ustyugov AA, Peters O, Khritankova I, Afanasieva MA, Tarasova TV, Alentov II, Buchman VL, Ninkina NN (2011) Dimebon slows progression of proteinopathy in gamma-synuclein transgenic mice. Neurotox Res, doi: 10.1007/s12640-011-9299-y.
59. Keil U, Scherping I, Hauptmann S, Schuessel K, Eckert A, Mueller WE (2006) Piracetam improves mitochondrial dysfunction following oxidative stress. Br J Pharmacol 147, 199-208. (Pubitemid 43151568)
60. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE (2009) Mito-chondrial dysfunction: Anearly eventinAlzheimer pathology accumulates with ageinADtransgenic mice. Neurobiol Aging 30, 1574-1586.
61. Twig G, Shirihai OS (2011) The interplay between mitochon-drial dynamics and mitophagy. Antioxid Redox Signal 14, 1939-1951.
62. Chen H, McCaffery JM, Chan DC (2007) Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130, 548-562. (Pubitemid 47198302)
63. Chen H, Chan DC (2009) Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 18, R169-R176.
64. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27, 433-446. (Pubitemid 351161653)
65. Busch KB, Bereiter-Hahn J, Wittig I, Schagger H, Jendrach M (2006) Mitochondrial dynamics generate equal distribution but patchwork localization of respiratory Complex I. Mol Memb Biol 23, 509-520. (Pubitemid 44837736)
66. Ojaimi J, Masters CL, Opeskin K, McKelvie P, Byrne E (1999) Mitochondrial respiratory chain activity in the human brain as a function of age. Mech Ageing Dev 111, 39-47. (Pubitemid 29486435)
67. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA (2009) S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105.